BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/26/2021 4:22:54 PM | Browse: 703 | Download: 1693
 |
Received |
|
2020-08-31 07:21 |
|
Peer-Review Started |
|
2020-08-31 07:21 |
|
First Decision by Editorial Office Director |
|
2020-11-03 23:52 |
|
Return for Revision |
|
2020-11-03 23:52 |
|
Revised |
|
2020-11-16 05:46 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-11-25 11:52 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-11-29 22:23 |
|
Articles in Press |
|
2020-11-29 22:23 |
|
Edit the Manuscript by Language Editor |
|
2020-12-08 09:17 |
|
Typeset the Manuscript |
|
2021-01-24 00:26 |
|
Publish the Manuscript Online |
|
2021-01-26 16:22 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Effectiveness of entecavir to prevent hepatocellular carcinoma development is genotype dependent in hepatitis B virus-associated liver cirrhosis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Kazuo Tarao, Akito Nozaki, Makoto Chuma, Masataka Taguri and Shin Maeda |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Kanagawa Association of Medical and Dental Practitioners |
|
|
| Corresponding Author |
Kazuo Tarao, MD, PhD, Director, Director, Department of Gastroenterology, Tarao’s Gastroenterological Clinic, 2-58-6, Taiyo Building Futamatagawa, Asahi-ku,, Yokohama City 241-0821, Japan. duoluoweih7@gmail.com |
| Key Words |
Hepatocellular carcinoma; Entecavir; Genotype of hepatitis B virus; Oral nucleos(t)ide analogue |
| Core Tip |
Entecavir was demonstrated to reduce the rate of hepatocellular carcinoma (HCC) in patients with hepatitis B virus (HBV) associated liver cirrhosis. The reduction rate of HCC differs in various regions of the world. We surveyed the differences based on published articles using PubMed (2004-2019). On entecavir administration, the incidence of HCC in genotype D regions (1.89 ± 0.28%/year, mean ± SE) was significantly lower than that in genotype C regions (2.91 ± 0.24%/year, P < 0.01). While, concerning the initial HBV-deoxyribonucleic acid levels, that in genotype C patients was nearly the same as that in genotype D patients. The effectiveness of entecavir to prevent HCC development in patient with HBV-associated liver cirrhosis is genotype dependent. |
| Publish Date |
2021-01-26 16:22 |
| Citation |
Tarao K, Nozaki A, Chuma M, Taguri M, Maeda S. Effectiveness of entecavir to prevent hepatocellular carcinoma development is genotype dependent in hepatitis B virus-associated liver cirrhosis. World J Hepatol 2021; 13(1): 144-150 |
| URL |
https://www.wjgnet.com/1948-5182/full/v13/i1/144.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v13.i1.144 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
